Jacob E. Koskimaki

发表

Computational Models of Algae Metabolism for Industrial Applications

Jason A. Papin, Anna S. Blazier, A. Clarens, 2013 .

Collagen IV and CXC chemokine-derived antiangiogenic peptides suppress glioma xenograft growth

Aleksander S. Popel, Elena Victoria Rosca, A. Popel, 2012, Anti-cancer drugs.

A Biomimetic Collagen Derived Peptide Exhibits Anti-Angiogenic Activity in Triple Negative Breast Cancer

Aleksander S. Popel, Zaver M. Bhujwalla, Noriko Mori, 2014, PloS one.

Synergy between a collagen IV mimetic peptide and a somatotropin-domain derived peptide as angiogenesis and lymphangiogenesis inhibitors

Aleksander S. Popel, Corban G. Rivera, Niranjan B. Pandey, 2012, Angiogenesis.

Development of a biomimetic peptide derived from collagen IV with anti-angiogenic activity in breast cancer

A. Popel, A. Wolff, Jacob E. Koskimaki, 2011, Cancer biology & therapy.

Cancer Registry Data Linkage of Electronic Health Record Data From ASCO's CancerLinQ: Evaluation of Advantages, Limitations, and Lessons Learned

K. Cronin, Robert S. Miller, D. Rivera, 2022, JCO clinical cancer informatics.

Serpin-derived peptides are antiangiogenic and suppress breast tumor xenograft growth.

Aleksander S Popel, Corban G. Rivera, A. Popel, 2012, Translational oncology.

Peptides derived from type IV collagen, CXC chemokines, and thrombospondin-1 domain-containing proteins inhibit neovascularization and suppress tumor growth in MDA-MB-231 breast cancer xenografts.

A. Popel, F. Vesuna, V. Raman, 2009, Neoplasia.

Anti-angiogenic peptides for cancer therapeutics.

Aleksander S Popel, Corban G. Rivera, A. Popel, 2011, Current pharmaceutical biotechnology.

Pentastatin-1, a collagen IV derived 20-mer peptide, suppresses tumor growth in a small cell lung cancer xenograft model

Emmanouil D Karagiannis, Aleksander S Popel, Benjamin C. Tang, 2010, BMC Cancer.

Inhibition of lymphangiogenesis and angiogenesis in breast tumor xenografts and lymph nodes by a peptide derived from transmembrane protein 45A.

Aleksander S Popel, A. Popel, Esak Lee, 2013, Neoplasia.

Structure–Activity Relationship Study of Collagen‐Derived Anti‐Angiogenic Biomimetic Peptides

A. Popel, Jacob E. Koskimaki, N. Pandey, 2012, Chemical biology & drug design.

Inhibition of breast cancer growth and metastasis by a biomimetic peptide

A. Popel, Esak Lee, Jacob E. Koskimaki, 2014, Scientific Reports.

Development of CancerLinQ, a Health Information Learning Platform From Multiple Electronic Health Record Systems to Support Improved Quality of Care.

W. Rubinstein, A. Stewart, Robert S. Miller, 2020, JCO clinical cancer informatics.

Long-term suppression of ocular neovascularization by intraocular injection of biodegradable polymeric particles containing a serpin-derived peptide.

P. Campochiaro, A. Popel, Jordan J. Green, 2013, Biomaterials.

Novel peptide-specific quantitative structure-activity relationship (QSAR) analysis applied to collagen IV peptides with antiangiogenic activity.

Aleksander S Popel, Corban G. Rivera, Joel S Bader, 2011, Journal of medicinal chemistry.

Long-term suppression of ocular neovascularization by intraocular injection of biodegradable polymeric particles containing a serpin-derived peptide.

P. Campochiaro, A. Popel, Ron B. Shmueli, 2013, Biomaterials.

Collagen IV and CXC chemokine-derived antiangiogenic peptides suppress glioma xenograft growth

A. Popel, J. Laterra, Jacob E. Koskimaki, 2012, Anti-cancer drugs.

Novel peptide-specific quantitative structure-activity relationship (QSAR) analysis applied to collagen IV peptides with antiangiogenic activity.

Corban G. Rivera, J. Bader, A. Popel, 2011, Journal of medicinal chemistry.

Inhibition of breast cancer growth and metastasis by a biomimetic peptide

A. Popel, Esak Lee, Jacob E. Koskimaki, 2014, Scientific Reports.

Peptides derived from type IV collagen, CXC chemokines, and thrombospondin-1 domain-containing proteins inhibit neovascularization and suppress tumor growth in MDA-MB-231 breast cancer xenografts.

A. Popel, F. Vesuna, V. Raman, 2009, Neoplasia.